Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
Article, Comments

Ars Technica
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
Markers released top-line results today after previously reporting the trial succeeded.
21
15
4
4
3
2
2
1October 25, 2026 2.2K